NPSP: To Present At Piper Jaffray Health Care Conference @ 12:00 ET [delayed] -
NPS Pharmaceuticals Jumps On Study On Short Bowel Syndrome Drug -
NPSP: Begins Enrollment for Phase 3 Trial of GATTEX(TM) -
NPS Pharmaceuticals to Present at Piper Jaffray Health Care Conference -
NPSP: To Present At Rodman & Renshaw Investment Conference @ 16:30 ET [delayed] -
NPS Pharmaceuticals to Present at Rodman & Renshaw Healthcare Conference -
BRIEF-NPS Pharmaceuticals Q3 results -
NPS Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update -
NPSP: Q3 Earnings Call @ 08:00 ET Today [delayed] -
NPS Pharmaceuticals to Report Third Quarter 2008 Financial Results -
NPS reports positive interim data from Phase II hypoparathyroidism study -
NPS Pharmaceuticals to Report GATTEX(TM) Data at ESPEN, ACG, UEGW Congresses -
NPS Pharmaceuticals Picks Up Volume, Hits 2-Year High -
NPS Pharmaceuticals Reports Second Quarter Financial Results -
NPSP: Q2 Earnings Call @ 16:30 ET Today [delayed] -